John H Alexander1, Sumanas W Jordan2, Julie M West3, Amy Compston4, Jennifer Fugitt2, J Byers Bowen3, Gregory A Dumanian2, Raphael Pollock5, Joel L Mayerson1, Thomas J Scharschmidt1, Ian L Valerio3. 1. Department of Orthopaedics, The Ohio State University James Wexner Medical Center, Columbus, Ohio. 2. Division of Plastic Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 3. Department of Plastic Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio. 4. Department of Oncologic Rehabilitation, The Ohio State University James Comprehensive Cancer Center, Columbus, Ohio. 5. Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Abstract
BACKGROUND: We describe a multidisciplinary approach for comprehensive care of amputees with concurrent targeted muscle reinnervation (TMR) at the time of amputation. METHODS: Our TMR cohort was compared to a cross-sectional sample of unselected oncologic amputees not treated at our institution (N = 58). Patient-Reported Outcomes Measurement Information System (NRS, PROMIS) were used to assess postamputation pain. RESULTS: Thirty-one patients underwent amputation with concurrent TMR during the study; 27 patients completed pain surveys; 15 had greater than 1 year follow-up (mean follow-up 14.7 months). Neuroma symptoms occurred significantly less frequently and with less intensity among the TMR cohort. Mean differences for PROMIS pain intensity, behavior, and interference for phantom limb pain (PLP) were 5.855 (95%CI 1.159-10.55; P = .015), 5.896 (95%CI 0.492-11.30; P = .033), and 7.435 (95%CI 1.797-13.07; P = .011) respectively, with lower scores for TMR cohort. For residual limb pain, PROMIS pain intensity, behavior, and interference mean differences were 5.477 (95%CI 0.528-10.42; P = .031), 6.195 (95%CI 0.705-11.69; P = .028), and 6.816 (95%CI 1.438-12.2; P = .014), respectively. Fifty-six percent took opioids before amputation compared to 22% at 1 year postoperatively. CONCLUSIONS: Multidisciplinary care of amputees including concurrent amputation and TMR, multimodal postoperative pain management, amputee-centered rehabilitation, and peer support demonstrates reduced incidence and severity of neuroma and PLP.
BACKGROUND: We describe a multidisciplinary approach for comprehensive care of amputees with concurrent targeted muscle reinnervation (TMR) at the time of amputation. METHODS: Our TMR cohort was compared to a cross-sectional sample of unselected oncologic amputees not treated at our institution (N = 58). Patient-Reported Outcomes Measurement Information System (NRS, PROMIS) were used to assess postamputation pain. RESULTS: Thirty-one patients underwent amputation with concurrent TMR during the study; 27 patients completed pain surveys; 15 had greater than 1 year follow-up (mean follow-up 14.7 months). Neuroma symptoms occurred significantly less frequently and with less intensity among the TMR cohort. Mean differences for PROMIS pain intensity, behavior, and interference for phantom limb pain (PLP) were 5.855 (95%CI 1.159-10.55; P = .015), 5.896 (95%CI 0.492-11.30; P = .033), and 7.435 (95%CI 1.797-13.07; P = .011) respectively, with lower scores for TMR cohort. For residual limb pain, PROMIS pain intensity, behavior, and interference mean differences were 5.477 (95%CI 0.528-10.42; P = .031), 6.195 (95%CI 0.705-11.69; P = .028), and 6.816 (95%CI 1.438-12.2; P = .014), respectively. Fifty-six percent took opioids before amputation compared to 22% at 1 year postoperatively. CONCLUSIONS: Multidisciplinary care of amputees including concurrent amputation and TMR, multimodal postoperative pain management, amputee-centered rehabilitation, and peer support demonstrates reduced incidence and severity of neuroma and PLP.
Authors: Julie K Silver; Vishwa S Raj; Jack B Fu; Eric M Wisotzky; Sean Robinson Smith; Rebecca A Kirch Journal: Support Care Cancer Date: 2015-08-28 Impact factor: 3.603
Authors: Gregory A Dumanian; Jason H Ko; Kristina D O'Shaughnessy; Peter S Kim; Christopher J Wilson; Todd A Kuiken Journal: Plast Reconstr Surg Date: 2009-09 Impact factor: 4.730
Authors: D M Ehde; J M Czerniecki; D G Smith; K M Campbell; W T Edwards; M P Jensen; L R Robinson Journal: Arch Phys Med Rehabil Date: 2000-08 Impact factor: 3.966
Authors: Gregory A Dumanian; Benjamin K Potter; Lauren M Mioton; Jason H Ko; Jennifer E Cheesborough; Jason M Souza; William J Ertl; Scott M Tintle; George P Nanos; Ian L Valerio; Todd A Kuiken; A Vania Apkarian; Kyle Porter; Sumanas W Jordan Journal: Ann Surg Date: 2019-08 Impact factor: 12.969
Authors: Kevin Döring; Carmen Trost; Christoph Hofer; Martin Salzer; Tryphon Kelaridis; Reinhard Windhager; Gerhard M Hobusch Journal: Clin Orthop Relat Res Date: 2021-09-01 Impact factor: 4.755
Authors: David E Kurlander; Corinne Wee; Kyle J Chepla; Kyle D Lineberry; Tobias C Long; Joshua A Gillis; Ian L Valerio; Joseph S Khouri Journal: Plast Reconstr Surg Glob Open Date: 2020-10-27